Some diseases are borderline cases between these two fields of medicine and their treatment is difficult without considering both the neurological and the mental aspects of a given disease.

The mental health problems that remain within the area of our scientific interest and research include not only bipolar disorders, but also depression, anxiety disorders (neuroses), e.g. obsessive-compulsive disorder, anxiety or panic attacks, social phobia, generalised anxiety disorders, post-traumatic stress disorders or acute stress disorder. Our latest research elaborations concern schizophrenia. Our patented formulation for cariprazine is already present on the American market, and in the near future it will appear on the European market as well.

The portfolio of Gedeon Richter includes antidepressants and drugs used in the management of Alzheimer’s disease.

Source:

http://www.richter.hu/en-US/our-activity/in-focus/Pages/Central-Nervous-System.aspx